Economic Studies Ancillary to Completed or Ongoing Health Care Delivery and Financing Pilots, Demonstrations, and Other Experiments

by: TopGovernmentGrants Editorial Staff

The National Institutes of Health (NIH) is an agency operating within the Department of Human Health and Services and is responsible for the country's bio-medical and health-related research studies.

The NIH's efforts are mainly focused on obtaining new information to help prevent, detect, diagnose and treat a wide range of diseases and disabilities, all in the hopes of uncovering new knowledge that will lead to a better health for all.

In keeping with its goals and objectives, NIH has recently established a program entitled Economic Studies Ancillary to Completed or Ongoing Health Care Delivery and Financing Pilots, Demonstrations, and Other Experiments.

The goal of the Economic Studies Ancillary to Completed or Ongoing Health Care Delivery and Financing Pilots, Demonstrations, and Other Experiments program is to be able to seek high-quality, health economics research ancillary to large-scale federal and non-federal pilots, demonstrations, other experiments in areas of health care payment, structure, or health care organization that are currently seeking approaches that would reduce costs while simultaneously enhancing quality and outcomes.

As emphasized in the program's official announcement, the types of research that are encouraged may include:

a) Research studies that would boost the scientific yield of completed or ongoing Pilots, Demonstrations, and Other Experiments (PDEs)

b) Research studies that would improve the scientific yield of multi-site PDEs

c) Research studies that would formally test the effect of costs, quality, and patient outcomes of PDEs that have been the subject of less rigorous analyses.

  (continued...)

Economic Studies Ancillary to Completed or Ongoing Health Care Delivery and Financing Pilots, Demonstrations, and Other Experiments
  Page 2

About The Author The TopGovernmentGrants Editorial Staff maintains one the most comprehensive Websites offering information on government grants and federal government programs. The staff also provides resources to other Websites with information on environmental grants and grants for youth programs.

Additional Resources

category - Health Grants

Cancer Education Grants Program
The Cancer Education Grants Program has been existent since the year 1994 and has long been providing support to innovative cancer education grants program that aim to translate the knowledge obtain from the research studies into actual public health applications.

---

Early-Stage Innovative Technology Development for Cancer Research Program
The National Institutes of Health has collaborated with the National Cancer Institute(NCI) in order to establish Early-Stage Innovative Technology Development for Cancer Research Program, wherein both agencies intend to solicit grant applications expressing intents to conduct funded exploratory research projects that concentrate on the inception and development unique, innovative technological advances that could potentially be utilized in the study of cancer.

---

Department of Agriculture: Value Added Producer Grants
The Value-Added Producer Grants program is geared towards helping the Independent Producers of Agricultural Commodities, Agriculture Producer Groups, Farmer and Rancher Cooperatives, and Majority-Controlled Producer-Based Business Ventures in developing techniques that would create marketing opportunities and establish business plans involving viable marketing opportunities that involve the production of bio-based products from agricultural commodities.

---

Effect of Physicochemical Properties of Ophthalmic Formulations on Ocular Bioavailability Program
In this capacity, the Food and Drug Administration has recently established the Effect of Physicochemical Properties of Ophthalmic Formulations on Ocular Bioavailability Program in an attempt to study the effects of various physicochemical properties of ophthalmic suspensions and emulsions on ocular bioavailability.

---